Policy and Advocacy: Drug classification

Your search found Results 1 - 10 of 22:

Old dogma, new tricks

Wednesday, August 31, 2011

Adherence to the creed of prohibition is as strong as ever in many countries. But while the UK is still racked with crushing guilt about the original sin of drugs, New Zealand is now questioning the holy writ of its Drugs Act and edging gradually towards a new prohibitionist atheism. Jeremy Sare compares the two countries’ legislative approaches in the modern drugs era and asks where we should put out faith.

The Proposition

Tuesday, February 8, 2011

At the US mid-term elections last November, Californian voters rejected Proposition 19, a measure that would have allowed local bodies in the state to tax and regulate marijuana use. The losing margin was 8 percent or almost 700,000 votes, but, writes Hamish McKenzie, its supporters are not as disappointed as you might think.

Misuse of Drugs Act Amendment Bill

Sunday, September 19, 2010

The New Zealand Drug Foundation – Te Tūāpapa Tarukino o Aotearoa welcomes the opportunity to comment on the Misuse of Drugs Amendment Bill.  Our comments focus on the suggested initiatives around scheduling methamphetamine precursor substances ephedrine and pseudoephedrine as Class B2 controlled drugs and the extension of offence provisions for the importation of drug paraphernalia for supply.

The slow death of the ACMD

Sunday, May 30, 2010

As part of its drug law review, the Law Commission has recommended an overhaul of our Government’s drug classification body – the Expert Advisory Committee on Drugs. Internationally, these independent advisory bodies play an important role by injecting scientific expertise into the often fraught politics of drug policy.

Controlling and Regulating Drugs - an issues paper on the reform of New Zealand's drug laws

Thursday, April 29, 2010

The Drug Foundation has published its submission to the Law Commission's issues paper - "Controlling and Regulating Drugs" - on the reform of New Zealand’s drug laws.

Our comments on this report are influenced by our guiding principles, including a commitment to evidence-based best practice and policy, and harm minimisation. Information about the Drug Foundation is appended to this submission.

The Director's Cut - vol 19 no 4

Friday, November 27, 2009

In politics, it’s often said, if you’re explaining, you’re losing. This was the unnecessary position Prime Minister John Key found himself in following the launch of the government’s new methamphetamine action plan.

Stop making sense

Wednesday, May 13, 2009

In January 2004 the UK downgraded cannabis from Class B to Class C, which meant lower penalties and fewer arrests for possession. In January 2009 that decision was reversed, even though scientific advice had not changed significantly and cannabis consumption was falling.